U.S. Intergroup phase II trial (SWOG 1108) of alisertib, an investigational aurora A kinase (AAK) inhibitor, in patients with peripheral T-cell lymphoma (PTCL; NCT01466881).
Paul M. Barr
Consultant or Advisory Role - Millennium
Hongli Li
No relevant relationships to disclose
Catherine M Spier
No relevant relationships to disclose
Daruka Mahadevan
No relevant relationships to disclose
Jonathan W. Friedberg
No relevant relationships to disclose
Michael Leo LeBlanc
No relevant relationships to disclose
Mansoor Ul Haq
No relevant relationships to disclose
Christopher Flowers
Consultant or Advisory Role - Millennium (U)
Nina D. Wagner-Johnston
No relevant relationships to disclose
Bruce D. Cheson
No relevant relationships to disclose
Steven M. Horwitz
Consultant or Advisory Role - Millennium
Research Funding - Millennium
Thomas P. Miller
No relevant relationships to disclose
Richard I. Fisher
No relevant relationships to disclose